Maternal uniparental disomy of chromosome 14

disease
On this page

Also known as maternal uniparental disomy of chromosome type 14UPD(14)mat

Summary

Maternal uniparental disomy of chromosome 14 (MONDO:0019915) is a disease. A subtype of motor developmental delay due to 14q32.2 paternally expressed gene defect — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 35

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families64WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

35 HPO clinical features (Orphanet curated; top 35 by frequency):

HPO IDTermFrequency
HP:0000826Precocious pubertyVery frequent (80-99%)
HP:0001252HypotoniaVery frequent (80-99%)
HP:0001270Motor delayVery frequent (80-99%)
HP:0001773Short footVery frequent (80-99%)
HP:0008897Postnatal growth retardationVery frequent (80-99%)
HP:0200055Small handVery frequent (80-99%)
HP:0000750Delayed speech and language developmentFrequent (30-79%)
HP:0001249Intellectual disabilityFrequent (30-79%)
HP:0001382Joint hypermobilityFrequent (30-79%)
HP:0001511Intrauterine growth retardationFrequent (30-79%)
HP:0001513ObesityFrequent (30-79%)
HP:0001518Small for gestational ageFrequent (30-79%)
HP:0001622Premature birthFrequent (30-79%)
HP:0001956Truncal obesityFrequent (30-79%)
HP:0004322Short statureFrequent (30-79%)
HP:0000028CryptorchidismOccasional (5-29%)
HP:0000160Narrow mouthOccasional (5-29%)
HP:0000175Cleft palateOccasional (5-29%)
HP:0000193Bifid uvulaOccasional (5-29%)
HP:0000218High palateOccasional (5-29%)
HP:0000293Full cheeksOccasional (5-29%)
HP:0000322Short philtrumOccasional (5-29%)
HP:0000347MicrognathiaOccasional (5-29%)
HP:0000403Recurrent otitis mediaOccasional (5-29%)
HP:0000445Wide noseOccasional (5-29%)
HP:0000463Anteverted naresOccasional (5-29%)
HP:0002021Pyloric stenosisOccasional (5-29%)
HP:0002650ScoliosisOccasional (5-29%)
HP:0003124HypercholesterolemiaOccasional (5-29%)
HP:0004904Maturity-onset diabetes of the youngOccasional (5-29%)
HP:0005280Depressed nasal bridgeOccasional (5-29%)
HP:0007010Poor fine motor coordinationOccasional (5-29%)
HP:0011220Prominent foreheadOccasional (5-29%)
HP:0011968Feeding difficultiesOccasional (5-29%)
HP:0030084ClinodactylyOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namematernal uniparental disomy of chromosome 14
Mondo IDMONDO:0019915
Orphanet96184
ICD-11171193570
UMLSC5680248
MedGen1841563
GARD0016848
Is cancer (heuristic)no

Also known as: maternal uniparental disomy of chromosome type 14 · UPD(14)mat

Disease family

This is a subtype of motor developmental delay due to 14q32.2 paternally expressed gene defect. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › syndromic diseasemotor developmental delay due to 14q32.2 paternally expressed gene defectmaternal uniparental disomy of chromosome 14

Related subtypes (2): paternal 14q32.2 microdeletion syndrome, paternal 14q32.2 hypomethylation syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.